![]()
|
||||||||||
![]()
|
||||||||||
![]()
|
||||||||||
![]()
|
||||||||||
| Placebo, week by week: | ||||||||||
| Week | ADAS-cog | DAD | NTB | CDR-SB | Warning: the ICAD presentation materials do not | |||||
| 0 | 0.00 | 0.00 | 0.00 | 0.00 | give the details of the Completer placebos, so we | |||||
| 11 | -1.00 | -4.00 | -0.01 | -0.60 | assume here, perhaps incorrectly, that the Completer | |||||
| 24 | -1.80 | -5.00 | -0.09 | -1.20 | placebos scored exactly the same as the | |||||
| 37 | -3.00 | -8.00 | -0.11 | -1.70 | MITT placebos. | |||||
| 50 | -7.00 | -11.00 | -0.22 | -2.20 | ||||||
| 63 | -8.00 | -16.00 | -0.30 | -3.20 | ||||||
| 78 | -11.00 | -21.50 | -0.50 | -4.20 | ||||||
| Completer - Non-carrier | ||||||||||
| ADAS-cog | ADAS-cog | ADAS-cog | ADAS-cog | ADAS-cog | ||||||
| Week | 0.15 | 0.50 | 1.00 | 2.00 | All | |||||
| 0 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| 11 | -1.42 | 1.58 | -1.78 | -0.28 | -0.62 | |||||
| 24 | -2.83 | 3.17 | -3.57 | -0.57 | -1.23 | |||||
| 37 | -4.25 | 4.75 | -5.35 | -0.85 | -1.85 | |||||
| 50 | -5.67 | 6.33 | -7.13 | -1.13 | -2.47 | |||||
| 63 | -7.08 | 7.92 | -8.92 | -1.42 | -3.08 | |||||
| 78 | -8.50 | 9.50 | -10.70 | -1.70 | -3.70 | |||||
| NTB | NTB | NTB | NTB | NTB | ||||||
| Week | 0.15 | 0.50 | 1.00 | 2.00 | All | |||||
| 0 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| 11 | -0.06 | 0.10 | -0.04 | -0.04 | -0.02 | |||||
| 24 | -0.11 | 0.19 | -0.07 | -0.08 | -0.05 | |||||
| 37 | -0.17 | 0.29 | -0.11 | -0.12 | -0.07 | |||||
| 50 | -0.22 | 0.39 | -0.14 | -0.16 | -0.09 | |||||
| 63 | -0.28 | 0.48 | -0.18 | -0.20 | -0.12 | |||||
| 78 | -0.33 | 0.58 | -0.21 | -0.24 | -0.14 | |||||
| DAD | DAD | DAD | DAD | DAD | ||||||
| Week | 0.15 | 0.50 | 1.00 | 2.00 | All | |||||
| 0 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| 11 | -3.03 | 1.05 | -5.05 | -1.22 | -2.23 | |||||
| 24 | -6.07 | 2.10 | -10.10 | -2.43 | -4.47 | |||||
| 37 | -9.10 | 3.15 | -15.15 | -3.65 | -6.70 | |||||
| 50 | -12.13 | 4.20 | -20.20 | -4.87 | -8.93 | |||||
| 63 | -15.17 | 5.25 | -25.25 | -6.08 | -11.17 | |||||
| 78 | -18.20 | 6.30 | -30.30 | -7.30 | -13.40 | |||||
| CDR-SB | CDR-SB | CDR-SB | CDR-SB | CDR-SB | ||||||
| Week | 0.15 | 0.50 | 1.00 | 2.00 | All | |||||
| 0 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| 11 | -0.48 | 0.62 | -0.95 | -0.52 | -0.42 | |||||
| 24 | -0.97 | 1.23 | -1.90 | -1.03 | -0.83 | |||||
| 37 | -1.45 | 1.85 | -2.85 | -1.55 | -1.25 | |||||
| 50 | -1.93 | 2.47 | -3.80 | -2.07 | -1.67 | |||||
| 63 | -2.42 | 3.08 | -4.75 | -2.58 | -2.08 | |||||
| 78 | -2.90 | 3.70 | -5.70 | -3.10 | -2.50 | |||||
| Tan means "interpolated" | ||||||||||
| Dark yellow means "estimated from line graphs on page 18. | ||||||||||
| Blue means "read directly from the bar value, p. 16" | ||||||||||